Wolverine Trading’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$551K Sell
1,100
-100
-8% -$43.7K ﹤0.01% 3601
2025
Q2
$373K Sell
1,200
-200
-14% -$60K ﹤0.01% 3241
2025
Q1
$437K Buy
1,400
+200
+17% +$67.3K ﹤0.01% 3122
2024
Q4
$400K Sell
1,200
-2,100
-64% -$712K ﹤0.01% 3669
2024
Q3
$1.09M Buy
3,300
+1,600
+94% +$608K ﹤0.01% 2258
2024
Q2
$700K Buy
1,700
+400
+31% +$158K ﹤0.01% 2515
2024
Q1
$525K Sell
1,300
-2,900
-69% -$1.02M ﹤0.01% 2794
2023
Q4
$1.29M Buy
+4,200
New +$1.13M ﹤0.01% 2055
2022
Q1
Sell
-2,400
Closed -$526K 6031
2021
Q4
$526K Buy
2,400
+200
+9% +$41.9K ﹤0.01% 3389
2021
Q3
$413K Buy
+2,200
New +$401K ﹤0.01% 4225
2021
Q1
Sell
-3,000
Closed -$414K 6199
2020
Q4
$414K Buy
+3,000
New +$378K ﹤0.01% 3378
2020
Q2
Sell
-3,400
Closed -$255K 4961
2020
Q1
$255K Sell
3,400
-2,100
-38% -$182K ﹤0.01% 3403
2019
Q4
$458K Sell
5,500
-4,600
-46% -$356K ﹤0.01% 3148
2019
Q3
$840K Sell
10,100
-6,300
-38% -$476K ﹤0.01% 2124
2019
Q2
$1.07M Sell
16,400
-13,100
-44% -$755K ﹤0.01% 1980
2019
Q1
$1.74M Buy
29,500
+22,500
+321% +$1.34M 0.01% 1648
2018
Q4
$363K Sell
7,000
-4,500
-39% -$247K ﹤0.01% 2979
2018
Q3
$689K Buy
+11,500
New +$629K ﹤0.01% 2741

Other funds holding MEDP

Wolverine Trading's MEDP Position: Q4 2024 in Review

Wolverine Trading sold out of Medpace (MEDP) in Q4 2024, closing a stake of 790 shares — an estimated $268K sold.

Wolverine Trading first reported a position in MEDP in Q1 2018 and held it in 12 quarters. The position peaked at $1.53M in Q3 2018. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Wolverine Trading reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 790 Medpace shares in Q4 2024, an estimated $268K.
  • Wolverine Trading first reported a position in Medpace in Q1 2018 and held it in 12 quarters.
  • Wolverine Trading's Medpace position peaked at $1.53M in Q3 2018.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.